Clinical Trial

Healthy heaAring for Healthy Ageing: Data-driven Hearing Rehabilitation Intervention to Promote Healthy Hearing

Study acronym: HAHA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of the HAHA trial is to prove that the treatment of HI and prevention of HI-related cognitive decline are most likely to be effective if HI is approached as a broader neurodegenerative entity with multifaceted manifestations currently unaddressed in clinical practice and managed using a novel individualised data-driven protocol for early hearing rehabilitation. The main hypothesis is that, compared with standard care, the data-driven rehabilitation will likely have broader benefits manifested in three key areas: hearing, cognition, and quality of life and psychosocial outcomes. Participants will be randomized 1:1 to either intervention (individualised data-driven hearing rehabilitation) or control group (standard care hearing rehabilitation). The primary objective of this study is to investigate the effect of an optimized data-driven hearing rehabilitation protocol versus standard care protocol on change in speech perception in noise (SPIN) in older adults with mild to moderately severe sensorineural HI and without dementia.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-02; most recent amendment 2026-03-02.
Status change: Recruiting → Active, Not Recruiting 2026-03-02
Status change: Not Yet Recruiting → Recruiting 2024-10-22
Trial Details
NCT Number NCT06495268
Lead Sponsor Kuopio University Hospital
Collaborators: University of Eastern Finland
Conditions Sensorineural Hearing Loss, Cognitive Decline
Enrollment 200 participants
Start Date 2024-10-01
Primary Completion 2028-02-29 (estimated)
Study Completion 2028-02-29 (estimated)
Updated on ClinicalTrials.gov 2026-03-04